Advance your understanding of major diseases of the modern world and the latest research into treatments.
Our intercalated BSc in Experimental Pathology gives students already taking a medical or dental degree the chance to achieve an additional degree in this specialist field in just one year.
The programme is ideal if you want to specialise in the study of disease. It's designed to give you a thorough grounding in specific areas of experimental pathology, covering some of the major diseases of the modern world – from cardiovascular, inflammatory and neurodegenerative diseases to cancer and haematological disorders.
Teaching emphasises the importance of research and experimentation, and how the latest technological innovations can benefit patients. Core modules include experimental neuropathology, cardiovascular pathophysiology and cancer, with a range of option modules including the science of biocompatibility and experimental haematology.
You'll undertake your own original research project under supervision over a six-month period, which will allow you to think creatively and develop skills such as work planning, forming hypotheses and analysing data.
At Queen Mary, we have been adapting to the challenges of Covid-19 so we are ready for the new academic year, with all the academic, pastoral and community support you need to settle in and thrive. For your chosen programme of study, the result is an innovative blended learning offering, giving you access to a world-class education whether or not you can join us on campus from September. For more information, please visit our dedicated FAQ pages.
You can start your one-year intercalated Experimental Pathology BSc after the second, third or fourth years of your MBBS, BDS or BVetMed.
Please note that all modules are subject to change.
An intercalated degree will broaden your studies as you gain an additional qualification.
It will also:
You'll receive approximately three hours of weekly contact time per taught module, comprising formal lectures – including from colleagues in the NHS and, in some cases, specialists from abroad.
For every hour spent in class, you'll complete a further six hours of independent study.
Assessment typically includes a combination of exams, coursework and project write up.
The School offers excellent on-campus resources to aid your studies. You’ll be based in the Blizard Building, which houses state-of-the-art facilities for students and staff including open-plan research laboratories, a 400-seat lecture theatre and a café.
You’ll also have access to:
UK students accepted onto this course are eligible to apply for from Student Finance England or other government bodies.
Medical and dental students from Barts and The London will be considered for various bursaries based on research interests, financial need or academic merit.
These bursaries are not available to students from other medical schools, or to Barts and The London students who choose to intercalate externally.
We offer specialist support on all financial and welfare issues through our Advice and Counselling Service, which you can access as soon as you have applied for a place at Queen Mary.
Take a look at our Student Advice Guides which cover ways to finance your degree, including:
With its focus on research, this programme forms a strong basis for careers in academic medicine. Your in-depth understanding of major diseases such as cancer and heart disease will be also be an advantage in clinical work.
The Blizard Institute is the largest institute within Barts and the London School of Medicine and Dentistry. We aim to deliver excellence in all aspects of research, teaching and clinical service: our research output is ranked joint first in the UK for hospital based clinical research and first in London for health services research.
We work in partnerships with neighbouring NHS Trusts, healthcare professionals and local communities on research to address the health needs of our local population.
The Global Public Health Unit brings together leading researchers and teachers in public health policy, all of whom share a commitment to reducing health inequalities and promoting universal health care in and beyond the UK.